ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/08/2026
Back to search
Official data from USPTO
SPEVIGO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
07/08/2026
Trademark type
Word
Nice classes
5
Filing date
02/22/2022
Registration date
10/17/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/17/2023
Last transaction
07/08/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/01/2022
First use in commerce
09/01/2022
Drawing code
4
Owner type
65
Owner location
BALLERUP, DK
Examiner
PRIZANT, JAMES
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
LEO PHARMA A/S
Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH
Representatives
Max Moskowitz OSTROLENK FABER LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders and of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular systemmusculoskeletal systemcentral nervous systemperipheral nervous systemgenitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disordersdamaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; Pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; Pharmaceutical preparationscell based immune therapeutics for treatment of cancerfor treatment of immunological diseasestreatment of infectious diseases
Publications
History of USPTO decisions and trademark events.
17 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/17/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
10/17/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/09/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/08/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/02/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/02/2023
IUAF
USE AMENDMENT FILED
07/14/2023
EISU
TEAS STATEMENT OF USE RECEIVED
07/14/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/21/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/27/2022
PUBO
PUBLISHED FOR OPPOSITION
12/27/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/07/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/21/2022
DOCK
ASSIGNED TO EXAMINER
11/19/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/28/2022
NWAP
NEW APPLICATION ENTERED
02/25/2022
Continuous trademark protection
Get notified about every new filing that threatens SPEVIGO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.